Montefiore Einstein Cancer Center Study Shows that a Low-cost Antibacterial Regimen Can Prevent Acute Radiation Dermatitis BRONX - Acute radiation dermatitis (ARD)—characterized by red, sore, itchy or peeling skin—affects up to 95% of people undergoing radiation treatment for cancer. Severe cases can cause significant swelling and painful skin ulcers that can severely impair quality of life, yet little is known about why this condition occurs and no standardized treatments for preventing severe ARD have been widely adapted. Researchers at Montefiore Einstein Cancer Center (MECC) have found that many cases of ARD involve a common skin bacterium and that a simple, low-cost treatment can prevent severe cases, potentially setting a new standard of care for people undergoing radiation therapy. Their findings were reported in two papers published today in JAMA Oncology . Each year, 10 million people are treated with radiation therapy to reduce the size of their tumors.
Comments
Post a Comment